0324 GMT July 24, 2021
Planning has been done for the production of one million doses of an Iranian COVID-19 vaccine, dubbed Razi COV-Pars, per month as of late August, said a deputy head of Razi Vaccine and Serum Research Institute (RVSRI).
The ground has been prepared for the industrial production of the jab, of which one million doses will be produced in the first phase, added Dr. Mohammad-Hassan Fallah-Mehrabadi, the RVSRI’s deputy head for research and technology, speaking to IRNA.
He noted that after the Iranian Health Ministry approves the jab, it will receive the said amount of the vaccine per month.
Fallah-Mehrabadi described as favorable the progress of the clinical trial of the vaccine, saying the effectiveness of the jab in developing immunity against the coronavirus will most probably be confirmed by late July, which will be followed by the mass production of vaccine.
He added the second phase of the vaccine’s clinical trial, which involved giving the jab to over 200 volunteers, ended on June 9.
RVSRI began the development of the vaccine in March 2020.
On Monday, Health Minister Saeed Namaki said the emergency use authorization for the first Iranian COVID-19 vaccine, dubbed COVIran Barakat, has been granted.
He added, “Today, Iran obtained the emergency use authorization for COVIran Barakat jab,” IRNA reported.
The vaccine has been developed by Iranian experts of the Execution of Imam Khomeini’s Order (EIKO).
Following the announcement, Mohammad Mokhber, the EIKO’s head, congratulated Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei in a letter on the approval of COVIran Barakat vaccine for emergency use and the country’s success in joining the group of six major COVID jab producers in the world.
He noted that the achievement was made in the light of the God’s providence, the Leader’s supports and prayers and efforts by the country’s experts.
Mokhber added by late September Iran will produce 50 million doses of the jab.
The Iranian Health Ministry announced on Friday that the country’s daily COVID-19 deaths and infections during the past 24 hours stood at 127 and 10,100, respectively, according to IRNA.
The statement said the total COVID-19 death toll and infections since the outbreak in late February 2020 stand at 82,746 and 3,080,526, respectively.
It added that 3,316 COVID-19 patients are in critical condition, and of the newly-detected cases, 1,357 individuals have been hospitalized.
The ministry said 2,722,612 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
It also announced that 22,194,745 coronavirus diagnostic tests have so far been carried out, and 5,264,091 doses of COVID-19 vaccines have been administered to people.
The Health Ministry said 22 cities in the country are coded red (very high-risk), while 175 are in the orange zone (high-risk), noting that based on a decision by the National Task Force for Fighting the Coronavirus, travel to and from these cities is prohibited.
The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 251 and zero, respectively, according to the ministry’s Monday statement.
Iran has been grappling with the fourth wave of COVID-19 infections over the past few weeks that has caused the country to see daily record-high deaths and infections of above 450 and 21,000 and impose a partial lockdown in very high-risk cities, closing certain businesses and public places.